Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

Yuen Siang Ang; Gerard E. Bruder; John G. Keilp; Ashleigh Rutherford; Daniel M. Alschuler; Pia Pechtel; Christian A. Webb; Thomas Carmody; Maurizio Fava; Cristina Cusin; Patrick J. McGrath; Myrna Weissman; Ramin Parsey; Maria A. Oquendo; Melvin G. McInnis; Crystal M. Cooper; Patricia Deldin; Madhukar H. Trivedi; Diego A. Pizzagalli

doi:10.1017/S0033291720004286

Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

Yuen Siang Ang, Gerard E. Bruder, John G. Keilp, Ashleigh Rutherford, Daniel M. Alschuler, Pia Pechtel, Christian A. Webb, Thomas Carmody, Maurizio Fava, Cristina Cusin, Patrick J. McGrath, Myrna Weissman, Ramin Parsey, Maria A. Oquendo, Melvin G. McInnis, Crystal M. Cooper, Patricia Deldin, Madhukar H. Trivedi, Diego A. Pizzagalli

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	2441-2449
Number of pages	9
Journal	Psychological Medicine
Volume	52
Issue number	13
DOIs	https://doi.org/10.1017/S0033291720004286
Publication status	Published - Oct 20 2022
Externally published	Yes

ASJC Scopus Subject Areas

Psychiatry and Mental health
Applied Psychology

Keywords

Biomarkers
bupropion
cognitive control
depression
placebo response
reward learning
sertraline
treatment response

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/S0033291720004286

Cite this

Ang, Y. S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., McGrath, P. J., Weissman, M., Parsey, R., Oquendo, M. A., McInnis, M. G., Cooper, C. M., Deldin, P., Trivedi, M. H., & Pizzagalli, D. A. (2022). Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychological Medicine, 52(13), 2441-2449. https://doi.org/10.1017/S0033291720004286

Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. / Ang, Yuen Siang; Bruder, Gerard E.; Keilp, John G. et al.
In: Psychological Medicine, Vol. 52, No. 13, 20.10.2022, p. 2441-2449.

Research output: Contribution to journal › Article › peer-review

Ang, YS, Bruder, GE, Keilp, JG, Rutherford, A, Alschuler, DM, Pechtel, P, Webb, CA, Carmody, T, Fava, M, Cusin, C, McGrath, PJ, Weissman, M, Parsey, R, Oquendo, MA, McInnis, MG, Cooper, CM, Deldin, P, Trivedi, MH & Pizzagalli, DA 2022, 'Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial', Psychological Medicine, vol. 52, no. 13, pp. 2441-2449. https://doi.org/10.1017/S0033291720004286

@article{b29202c7215a4da889ca1040ace5bd60,

title = "Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial",

keywords = "Biomarkers, bupropion, cognitive control, depression, placebo response, reward learning, sertraline, treatment response",

author = "Ang, {Yuen Siang} and Bruder, {Gerard E.} and Keilp, {John G.} and Ashleigh Rutherford and Alschuler, {Daniel M.} and Pia Pechtel and Webb, {Christian A.} and Thomas Carmody and Maurizio Fava and Cristina Cusin and McGrath, {Patrick J.} and Myrna Weissman and Ramin Parsey and Oquendo, {Maria A.} and McInnis, {Melvin G.} and Cooper, {Crystal M.} and Patricia Deldin and Trivedi, {Madhukar H.} and Pizzagalli, {Diego A.}",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2020. Published by Cambridge University Press.",

year = "2022",

month = oct,

day = "20",

doi = "10.1017/S0033291720004286",

language = "English",

volume = "52",

pages = "2441--2449",

journal = "Psychological Medicine",

issn = "0033-2917",

publisher = "Cambridge University Press",

number = "13",

}

TY - JOUR

T1 - Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

AU - Ang, Yuen Siang

AU - Bruder, Gerard E.

AU - Keilp, John G.

AU - Rutherford, Ashleigh

AU - Alschuler, Daniel M.

AU - Pechtel, Pia

AU - Webb, Christian A.

AU - Carmody, Thomas

AU - Fava, Maurizio

AU - Cusin, Cristina

AU - McGrath, Patrick J.

AU - Weissman, Myrna

AU - Parsey, Ramin

AU - Oquendo, Maria A.

AU - McInnis, Melvin G.

AU - Cooper, Crystal M.

AU - Deldin, Patricia

AU - Trivedi, Madhukar H.

AU - Pizzagalli, Diego A.

PY - 2022/10/20

Y1 - 2022/10/20

KW - Biomarkers

KW - bupropion

KW - cognitive control

KW - depression

KW - placebo response

KW - reward learning

KW - sertraline

KW - treatment response

UR - http://www.scopus.com/inward/record.url?scp=85096686358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096686358&partnerID=8YFLogxK

U2 - 10.1017/S0033291720004286

DO - 10.1017/S0033291720004286

M3 - Article

AN - SCOPUS:85096686358

SN - 0033-2917

VL - 52

SP - 2441

EP - 2449

JO - Psychological Medicine

JF - Psychological Medicine

IS - 13

ER -

Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this